CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy
A specialized edition intended for medical institutions and doctors.
18 September 2018

Dmytro Shymkiv becomes a chair member of the Pharmaceutical company Darnitsa

Dmytro Shymkiv became a chairman of the board of the PrJSC “Pharmaceutical Firm “Darnitsa”. He will be responsible for international affairs, strategic planning, development, and new technologies implementation.

Dmytro Shymkiv chaired the board of the PrJSC “Pharmaceutical Firm “Darnitsa” managing company. He will be responsible for international affairs, strategic planning, development, and new technologies implementation.

Dmytro Shymkiv – is a business person and top-manager of the innovations sphere with the 20-years-experience of work on managing positions in Ukraine, Europe, and the United States. In

 In 2007 he started working in “Microsoft Ukraine”, and in 2009-2014 he was head of the company’s branch in Ukraine.

From July 2014 until August 2018 he had been working as the deputy head of the Presidential Administration of Ukraine. Over a period of his service, he took part in the creation of the National Reforms Council, the launch of 3G and 4G in Ukraine. Dmytro Shymkiv also was behind the launch of the electronic public procurement system ProZorro, took part in creating a steady development strategy “Ukraine-2020”.

Moreover, the GoGlobal project of English language studies and popularization and Digital Ukraine was also launched with the help of Shymkiv.

Shymkiv also took part in the creation of Ukrainian cultural fund, the cyber protection system for Presidential Administration and many other reforms, initiatives, and innovations.

“Darnitsa” – is a modern, dynamic and profitable Ukrainian company. It is an interesting challenge for as a businessman to bring it to the club of international pharmaceutical players. It is also appealing for me that Darnitsa not only creates the added value on its production in Ukraine but also invests it in Ukraine,” Shymkiv said.

“We are pleased by the fact that Dmytro Shymkiv joined our team. The managing experience, he got while working in top companies, Ukrainian and international ones, would definitely become a significant contribution to “Darnitsa” strategic goal - to hold the leadership position on Ukrainian market and became the powerful player on global pharmaceuticals market,” said Svitlana Didenko, CEO of PrJSC “Pharmaceutical Firm “Darnitsa”.

To share